{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T11:58:43Z","timestamp":1722686323856},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2014,2,7]],"date-time":"2014-02-07T00:00:00Z","timestamp":1391731200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0088177","type":"journal-article","created":{"date-parts":[[2014,2,7]],"date-time":"2014-02-07T21:46:57Z","timestamp":1391809617000},"page":"e88177","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Prevalence of Anti-Citrullinated Protein Antibodies (ACPA) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL): A Case-Control Study"],"prefix":"10.1371","volume":"9","author":[{"given":"Gunter","family":"Assmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klara","family":"Shihadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viola","family":"Poeschel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niels","family":"Murawski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jutta","family":"Conigliarou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei Fang","family":"Ong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Pfreundschuh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,2,7]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/ijc.24141","article-title":"Autoimmunity and lymphomagenesis","volume":"124","author":"LR Goldin","year":"2009","journal-title":"Int J Cancer"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1006\/bcmd.2001.0442","article-title":"The dual association between lymphoma and autoimmunity","volume":"27","author":"M Ehrenfeld","year":"2001","journal-title":"Blood Cells Mol Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1365-2796.2008.02029.x","article-title":"Autoimmune and inflammatory disorders and risk of malignant lymphomas-an update","volume":"264","author":"KE Smedby","year":"2008","journal-title":"J Intern Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/art.21675","article-title":"Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis","volume":"54","author":"E Baecklund","year":"2006","journal-title":"Arthritis Rheum"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"5164","DOI":"10.4049\/jimmunol.161.10.5164","article-title":"Acceleration of lpr lymphoproliferative and autoimmune disease by transgenic protein kinase CK2 alpha","volume":"161","author":"IR Rifkin","year":"1998","journal-title":"J Immunol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.coph.2004.02.009","article-title":"The role of the BAFF\/APRIL system in B cell homeostasis and lymphoid cancers","volume":"4","author":"F Mackay","year":"2004","journal-title":"Curr Opin Pharmacol"},{"key":"ref7","first-page":"888","article-title":"Superior specificity of anti-citrullinated peptide antibodies in patients with chronic lymphocytic leukemia and arthritis","volume":"28","author":"K Brickmann","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"ref8","first-page":"502","article-title":"The prevalence and significance of autoantibodies in patients with non-Hodgkin\u2019s lymphoma: are they correlated with clinicopathological features?","volume":"17","author":"A Bilici","year":"2012","journal-title":"J BUON"},{"key":"ref9","first-page":"261","article-title":"Positivity for antinuclear antibody in patients with advanced rheumatoid arthritis","volume":"50","author":"S Nishimura","year":"1996","journal-title":"Acta Med Okayama"},{"key":"ref10","first-page":"485","article-title":"Prevalence of autoantibodies (ANA, anti ds-DNA, ENA, IMF) and rheumatic syndromes in patients with lymphoproliferative diseases","volume":"11","author":"A Chloraki-Bobota","year":"2006","journal-title":"J BUON"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1046\/j.1365-2141.2003.04587.x","article-title":"Prevalence and pattern of antinuclear autoantibodies in 347 patients with non-Hodgkin\u2019s lymphoma","volume":"123","author":"S Guyomard","year":"2003","journal-title":"Br J Haematol"},{"key":"ref12","first-page":"7","article-title":"Clinical significance of elevated antinuclear antibody test in patients with Hodgkin\u2019s and Non-Hodgkin\u2019s lymphoma: a single center experience","volume":"99","author":"A Altintas","year":"2008","journal-title":"Minerva Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","article-title":"The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide","volume":"43","author":"GA Schellekens","year":"2000","journal-title":"Arthritis Rheum"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/j.biocel.2006.03.008","article-title":"Citrullination: a posttranslational modification in health and disease","volume":"38","author":"B Gy\u00f6rgy","year":"2006","journal-title":"Int J Biochem Cell Biol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jbspin.2004.07.004","article-title":"Clinical and pathophysiological significance of the autoimmune response to citrullinated proteins in rheumatoid arthritis","volume":"71","author":"M Sebbag","year":"2004","journal-title":"Joint Bone Spine"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/ard.62.2.120","article-title":"Anticitrullinated protein\/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage","volume":"62","author":"O Meyer","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"ref17","first-page":"1587","article-title":"Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations., Ann Rheum Dis","volume":"63","author":"L De Rycke","year":"2004"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/annrheumdis-2012-202349","article-title":"Autoimmunity in rheumatoid arthritis: different antigens\u2013common principles","volume":"72","author":"LA Trouw","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","article-title":"Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors","volume":"50","author":"MM Nielen","year":"2004","journal-title":"Arthritis Rheum"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","article-title":"Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis","volume":"48","author":"S Rantap\u00e4\u00e4-Dahlqvist","year":"2003","journal-title":"Arthritis Rheum"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.smim.2011.01.014","article-title":"Smoking, citrullination and genetic variability in the immunopathogenesis of rheumatoid arthritis","volume":"23","author":"L Klareskog","year":"2011","journal-title":"Semin Immunol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1007\/s00296-012-2572-4","article-title":"Follow-up of primary Sjogren\u2019s syndrome patients presenting positive anti-cyclic citrullinated peptides antibody","volume":"33","author":"YS Ryu","year":"2013","journal-title":"Rheumatol Int"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"8761","DOI":"10.1158\/0008-5472.CAN-09-2280","article-title":"Regulation of protein Citrullination through p53\/PADI4 network in DNA damage response","volume":"69","author":"C Tanikawa","year":"2009","journal-title":"Cancer Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00109-008-0437-9","article-title":"On the origins of complex immune-mediated disease: the example of rheumatoid arthritis","volume":"87","author":"L Klareskog","year":"2009","journal-title":"J Mol Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1182\/blood-2003-06-2094","article-title":"Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL","volume":"104","author":"M Pfreundschuh","year":"2004","journal-title":"Blood"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1182\/blood-2003-06-2095","article-title":"Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL","volume":"104","author":"M Pfreundschuh","year":"2004","journal-title":"Blood"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"900","DOI":"10.3899\/jrheum.091110","article-title":"Genetic variations in genes encoding RANK, RANKL, and OPG in rheumatoid arthritis: a case-control study","volume":"37","author":"G Assmann","year":"2010","journal-title":"J Rheumatol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.atherosclerosis.2013.02.009","article-title":"Antibodies to citrullinated peptides and risk of coronary heart disease","volume":"228","author":"G Cambridge","year":"2013","journal-title":"Atherosclerosis"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/acr.21749","article-title":"Epidemiological Investigation of Rheumatoid Arthritis Study Group. Association between body mass index and anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis: results from a population-based case-control study","volume":"65","author":"A Wesley","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1002\/art.38097","article-title":"Familial risks and heritability of rheumatoid arthritis: role of rheumatoid factor\/anti-citrullinated protein antibody status, number and type of affected relatives, sex, and age","volume":"65","author":"T Frisell","year":"2013","journal-title":"Arthritis Rheum"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jaut.2011.12.001","article-title":"Sex differences and genomics in autoimmune diseases","volume":"38","author":"S Amur","year":"2012","journal-title":"J Autoimmun"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1182\/blood-2011-01-331462","article-title":"Toll-like receptor 7 (TLR7)-driven accumulation of a novel CD11c<sup>+<\/sup> B-cell population is important for the development of autoimmunity","volume":"118","author":"AV Rubtsov","year":"2011","journal-title":"Blood"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1084\/jem.20110640","article-title":"Autophagy in antigen-presenting cells results in presentation of citrullinated peptides to CD4 T cells","volume":"208","author":"JM Ireland","year":"2011","journal-title":"J Exp Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0198-8859(02)00414-7","article-title":"High dose chemotherapy and autologous hematopoietic stem cell transplantation for rheumatoid arthritis: a review","volume":"63","author":"Ro Verburg","year":"2002","journal-title":"Hum Immunol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/1529-0131(200104)44:4<754::AID-ANR131>3.0.CO;2-N","article-title":"High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis: results of an open study to assess feasibility, safety, and efficacy","volume":"44","author":"RJ Verburg","year":"2001","journal-title":"Arthritis Rheum"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0088177","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T10:19:30Z","timestamp":1688984370000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0088177"}},"subtitle":[],"editor":[{"given":"Massimo","family":"Pietropaolo","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,2,7]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,2,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0088177","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,7]]}}}